FMP
Integra LifeSciences Shares Plummet 17% Following Product Recall Announcement
May 23, 2023 5:08 PM - Davit Kirakosyan(Last modified: Dec 19, 2023 5:49 PM)
Image credit: FMP
Integra LifeSciences (NASDAQ:IART) shares experienced a significant drop of over 17% during today's trading as the company declared a voluntary worldwide recall of all its products made in its Boston, Massachusetts facility from March 1, 2018, to May 22, 2023.
Management discovered during an internal inquiry that there were "variations in endotoxin testing," which may have led to the potential sale of products exceeding the permissible levels of endotoxins. In response, it is (1) implementing additional detection and quality controls, after which it expects to resume manufacturing, (2) lowering Q2/23 revenue guidance to $372-376 million from $396-400 million and EPS to $0.55-0.59 from $0.75-0.79, and (3) expecting a Q2/23 $22 million inventory charge.
Other Blogs
Sep 10, 2024 7:33 AM - Parth Sanghvi
Best Alternatives to Yahoo Finance for Downloading Historical Stock Data
When it comes to downloading historical stock data, Yahoo Finance has been a popular choice for many. However, for those looking for more comprehensive, accurate, and flexible options, Financial Modeling Prep (FMP) offers a suite of powerful tools and services that stand out as superior alternatives...
Nov 8, 2024 5:30 AM - Sanzhi Kobzhan
Understanding Equity Valuation: When to Use DCF, DDM, and Price-Income (Multiplicators) Models
When it comes to investing in stocks, one of the key decisions an investor must make involves determining the intrinsic value of a company's shares. Equity valuation isn't just about numbers, it's an art mixed with science, aiming to predict future performance based on current and historical data. H...
Nov 22, 2024 5:08 AM - Parth Sanghvi
Fundamental Analysis: Principles, Types, and How to Use It
Fundamental analysis is one of the most essential tools for investors and analysts alike, helping them assess the intrinsic value of a stock, company, or even an entire market. It focuses on the financial health and economic position of a company, often using key data such as earnings, expenses, ass...
